Literature DB >> 35301051

Fibroblast growth factor 15/19 expression, regulation, and function: An overview.

Greg Guthrie1, Caitlin Vonderohe1, Douglas Burrin2.   

Abstract

Since the discovery of fibroblast growth factor (FGF)-19 over 20 years ago, our understanding of the peptide and its role in human biology has moved forward significantly. A member of a superfamily of paracrine growth factors regulating embryonic development, FGF19 is unique in that it is a dietary-responsive endocrine hormone linked with bile acid homeostasis, glucose and lipid metabolism, energy expenditure, and protein synthesis during the fed to fasted state. FGF19 achieves this through targeting multiple tissues and signaling pathways within those tissues. The diverse functional capabilities of FGF19 is due to the unique structural characteristics of the protein and its receptor binding in various cell types. This review will cover the current literature on the protein FGF19, its target receptors, and the biological pathways they target through unique signaling cascades. Published by Elsevier B.V.

Entities:  

Keywords:  Bile acid metabolism; Carbohydrate metabolism; Farnesoid x receptor; Fibroblast growth factor 19; Lipid metabolism; Protein synthesis

Mesh:

Substances:

Year:  2022        PMID: 35301051      PMCID: PMC9038700          DOI: 10.1016/j.mce.2022.111617

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.369


  162 in total

Review 1.  Evolution of the Fgf and Fgfr gene families.

Authors:  Nobuyuki Itoh; David M Ornitz
Journal:  Trends Genet       Date:  2004-11       Impact factor: 11.639

2.  Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.

Authors:  Hiroshi Kurosu; Mihwa Choi; Yasushi Ogawa; Addie S Dickson; Regina Goetz; Anna V Eliseenkova; Moosa Mohammadi; Kevin P Rosenblatt; Steven A Kliewer; Makoto Kuro-o
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

Review 3.  Isoforms of receptors of fibroblast growth factors.

Authors:  Siew-Ging Gong
Journal:  J Cell Physiol       Date:  2014-12       Impact factor: 6.384

4.  Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4.

Authors:  C Yu; F Wang; M Kan; C Jin; R B Jones; M Weinstein; C X Deng; W L McKeehan
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

Review 5.  Bile acid interactions with cholangiocytes.

Authors:  Xuefeng Xia; Heather Francis; Shannon Glaser; Gianfranco Alpini; Gene LeSage
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

6.  Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery.

Authors:  Peter L M Jansen; Jochem van Werven; Edo Aarts; Frits Berends; Ignace Janssen; Jaap Stoker; Frank G Schaap
Journal:  Dig Dis       Date:  2011-06-17       Impact factor: 2.404

7.  Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis.

Authors:  Stephen A Harrison; Guy Neff; Cynthia D Guy; Mustafa R Bashir; Angelo H Paredes; Juan P Frias; Ziad Younes; James F Trotter; Nadege T Gunn; Sam E Moussa; Anita Kohli; Kristin Nelson; Mildred Gottwald; William C G Chang; Andrew Z Yan; Alex M DePaoli; Lei Ling; Hsiao D Lieu
Journal:  Gastroenterology       Date:  2020-08-08       Impact factor: 22.682

8.  A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass.

Authors:  Glenn S Gerhard; Amanda M Styer; G Craig Wood; Stephen L Roesch; Anthony T Petrick; Jon Gabrielsen; William E Strodel; Christopher D Still; George Argyropoulos
Journal:  Diabetes Care       Date:  2013-07       Impact factor: 19.112

9.  Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.

Authors:  Chaofeng Yang; Chengliu Jin; Xiaokun Li; Fen Wang; Wallace L McKeehan; Yongde Luo
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

10.  Fibroblast growth factor receptor 4 (FGFR4) and fibroblast growth factor 19 (FGF19) autocrine enhance breast cancer cells survival.

Authors:  Kai Hung Tiong; Boon Shing Tan; Heng Lungh Choo; Felicia Fei-Lei Chung; Ling-Wei Hii; Si Hoey Tan; Nelson Tze Woei Khor; Shew Fung Wong; Sze-Jia See; Yuen-Fen Tan; Rozita Rosli; Soon-Keng Cheong; Chee-Onn Leong
Journal:  Oncotarget       Date:  2016-09-06
View more
  2 in total

Review 1.  Pathobiology of the Klotho Antiaging Protein and Therapeutic Considerations.

Authors:  Gérald J Prud'homme; Mervé Kurt; Qinghua Wang
Journal:  Front Aging       Date:  2022-07-12

2.  Association of extracellular vesicle inflammatory proteins and mortality.

Authors:  Nicole Noren Hooten; Stephanie Torres; Nicolle A Mode; Alan B Zonderman; Paritosh Ghosh; Ngozi Ezike; Michele K Evans
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.